Biogen Inc. (BIIB), headquartered in Cambridge, Massachusetts, specializes in discovering, developing, manufacturing, and delivering therapies for neurological and neurodegenerative diseases ...

Sage Therapeutics Inc. sued Biogen Inc. on Friday, a week after the biotech giant made an unsolicited offer to acquire the smaller neuroscience company for about $469 million. The lawsuit remains ...

Meat processing giant JBS appears to have watered down its sustainability ambitions by claiming that its 2040 net zero ‘commitment’ does not represent a ‘promise’. In March 2021 ...

The constraint has been a lack of good drugs to treat those patients. Eisai and Biogen, with Leqembi, and Eli Lilly, with Kisunla, have begun the process of establishing a drug arsenal for ...

In a report released today, David Amsellem from Piper Sandler reiterated a Hold rating on Biogen (BIIB – Research Report), with a price target of $138.00. The company’s shares closed yesterday ...

JBS USA Food Co., one of the nation's largest meatpacking processors and slaughterhouses, has agreed to a joint initiative with the U.S. Labor Department to end illegal child labor practices ...

Moreover, Biogen’s valuation appears to be fairly priced at current levels, as indicated by a Discounted Cash Flow analysis projecting revenues through 2033. While the company has potential ...

SAO PAULO - The world's largest meatpacker, JBS, became in 2021 the first of its peers to commit to cutting or offsetting all its emissions by 2040, and to ending illegal deforestation across its ...

Biogen Inc. (NASDAQ:BIIB), a leader in biotechnology, announced the appointment of Sean Godbout as Vice President, Chief Accounting Officer & Global Corporate Controller, effective March 1, 2025 ...

Exclusive-Brazilian Meatpacker JBS Says Net-Zero Emissions Pledge Was 'Never a Promise' By Stefanie Eschenbacher, Luciana Magalhaes and Simon Jessop SAO PAULO (Reuters) - The world's largest ...